CTC
ONC icon

Central Trust Company’s BeOne Medicines Ltd ONC Stock Holding History

Central Trust Company’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4
Closed -$1.19K – 1696
2026
Q1 		$1.19K Buy
+4
New +$1.29K ﹤0.01% 1404
2025
Q4 		– Hold
0
– – – 1528
2024
Q4 		– Sell
-1
Closed -$144 – 1519
2024
Q3 		$144 Buy
+1
New +$180 ﹤0.01% 1409
2020
Q2 		– Sell
-40
Closed -$5K – 1172
2020
Q1 		$5K Hold
40
– – ﹤0.01% 991
2019
Q4 		$7K Hold
40
– – ﹤0.01% 1007
2019
Q3 		$5K Hold
40
– – ﹤0.01% 1048
2019
Q2 		$5K Buy
+40
New +$5.08K ﹤0.01% 1040

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Central Trust Company's ONC Position: Q2 2026 in Review

Central Trust Company sold out of BeOne Medicines Ltd (ONC) in Q2 2026, closing a stake of 4 shares — an estimated $1.19K sold.

Central Trust Company first reported a position in ONC in Q2 2019 and held it in 6 quarters. The position peaked at $7K in Q4 2019. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Central Trust Company reported no remaining BeOne Medicines Ltd position as of Q2 2026 after selling out during the quarter.
  • Central Trust Company sold 4 BeOne Medicines Ltd shares in Q2 2026, an estimated $1.19K.
  • Central Trust Company first reported a position in BeOne Medicines Ltd in Q2 2019 and held it in 6 quarters.
  • Central Trust Company's BeOne Medicines Ltd position peaked at $7K in Q4 2019.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.